Arkolith/Insider Trading/KDMN/Form 4

Ryan John L

EVP, Chief Medical OfficerKadmon Holdings, Inc. (KDMN) · full profile →Form 4 · filed Nov 9, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 9, 2021Disposed to issuer(D)100K$4.84$484K0
Nov 9, 2021Disposed to issuer(D)150K$5.86$879K0
Nov 9, 2021Disposed to issuer(D)50K$7.03$352K0
Nov 9, 2021Disposed to issuer(D)100K$5.16$516K0
Nov 9, 2021Disposed to issuer(D)175K$5.54$970K0
Nov 9, 2021Disposed to issuer(D)250$3.50$8750

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-136410) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML